197 related articles for article (PubMed ID: 32547225)
1. Double Agent:
Ye T; Feng J; Wan X; Xie D; Liu J
Cancer Manag Res; 2020; 12():3891-3902. PubMed ID: 32547225
[TBL] [Abstract][Full Text] [Related]
2. SPDEF enhances cancer stem cell-like properties and tumorigenesis through directly promoting GALNT7 transcription in luminal breast cancer.
Li J; Wan X; Xie D; Yuan H; Pei Q; Luo Y; Chen Y; Xian J; Ye T
Cell Death Dis; 2023 Aug; 14(8):569. PubMed ID: 37633945
[TBL] [Abstract][Full Text] [Related]
3. The subtype-specific molecular function of SPDEF in breast cancer and insights into prognostic significance.
Ye T; Li J; Feng J; Guo J; Wan X; Xie D; Liu J
J Cell Mol Med; 2021 Aug; 25(15):7307-7320. PubMed ID: 34191390
[TBL] [Abstract][Full Text] [Related]
4. The role of SPDEF in cancer: promoter or suppressor.
Bao KC; Wang FF
Neoplasma; 2022 Dec; 69(6):1270-1276. PubMed ID: 35951453
[TBL] [Abstract][Full Text] [Related]
5. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
[TBL] [Abstract][Full Text] [Related]
6. Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis.
Sood AK; Wang J; Mhawech-Fauceglia P; Jana B; Liang P; Geradts J
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1899-903. PubMed ID: 19505923
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of SPDEF is associated with poor prognosis in prostate cancer.
Meiners J; Schulz K; Möller K; Höflmayer D; Burdelski C; Hube-Magg C; Simon R; Göbel C; Hinsch A; Reiswich V; Weidemann S; Izbicki JR; Sauter G; Jacobsen F; Möller-Koop C; Mandelkow T; Blessin NC; Lutz F; Viehweger F; Lennartz M; Fraune C; Heinzer H; Minner S; Bonk S; Huland H; Graefen M; Schlomm T; Büscheck F
Oncol Lett; 2019 Nov; 18(5):5107-5118. PubMed ID: 31612022
[TBL] [Abstract][Full Text] [Related]
8. Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2.
Tsai YC; Chen WY; Abou-Kheir W; Zeng T; Yin JJ; Bahmad H; Lee YC; Liu YN
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1717-1727. PubMed ID: 29477409
[TBL] [Abstract][Full Text] [Related]
9. In Silico Identification of Genes Associated with Breast Cancer Progression and Prognosis and Novel Therapeutic Targets.
Uchida S; Sugino T
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428562
[TBL] [Abstract][Full Text] [Related]
10. GADD45α and γ interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migration.
Tamura RE; Paccez JD; Duncan KC; Morale MG; Simabuco FM; Dillon S; Correa RG; Gu X; Libermann TA; Zerbini LF
Oncotarget; 2016 Mar; 7(12):13865-79. PubMed ID: 26885618
[TBL] [Abstract][Full Text] [Related]
11. SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1.
Wu J; Qin W; Wang Y; Sadik A; Liu J; Wang Y; Song P; Wang X; Sun K; Zeng J; Wang L
J Cell Biochem; 2018 Nov; 119(11):9042-9054. PubMed ID: 30076647
[TBL] [Abstract][Full Text] [Related]
12. ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer.
Turner DP; Watson DK
Expert Rev Anticancer Ther; 2008 Jan; 8(1):33-42. PubMed ID: 18095881
[TBL] [Abstract][Full Text] [Related]
13. Signatures of prostate-derived Ets factor (PDEF) in cancer.
Mahajan N
Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480
[TBL] [Abstract][Full Text] [Related]
14. New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.
Zhou K; Liu M; Cao Y
Front Mol Biosci; 2017; 4():46. PubMed ID: 28736730
[TBL] [Abstract][Full Text] [Related]
15. Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.
Tripathy D; Benz CC
Cancer Treat Res; 1992; 63():15-60. PubMed ID: 1363356
[TBL] [Abstract][Full Text] [Related]
16. Oncogenes and tumor suppressor genes in prostate cancer: a review.
Wang YZ; Wong YC
Urol Oncol; 1997; 3(2):41-6. PubMed ID: 21227058
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of expression profiles of microRNAs and two target genes, FOXO3a and RUNX2, effectively supports diagnostics and therapy predictions in breast cancer.
Jurkovicova D; Magyerkova M; Sestakova Z; Copakova L; Bella V; Konecny M; Krivjanska M; Kulcsar L; Chovanec M
Neoplasma; 2016; 63(6):941-951. PubMed ID: 27596294
[TBL] [Abstract][Full Text] [Related]
18. The ets-domain transcription factor Spdef promotes maturation of goblet and paneth cells in the intestinal epithelium.
Gregorieff A; Stange DE; Kujala P; Begthel H; van den Born M; Korving J; Peters PJ; Clevers H
Gastroenterology; 2009 Oct; 137(4):1333-45.e1-3. PubMed ID: 19549527
[TBL] [Abstract][Full Text] [Related]
19. The Emerging Role of MicroRNAs in Breast Cancer.
Yang Z; Liu Z
J Oncol; 2020; 2020():9160905. PubMed ID: 32714393
[TBL] [Abstract][Full Text] [Related]
20. miR-125b inhibits goblet cell differentiation in allergic airway inflammation by targeting SPDEF.
Liu Z; Chen X; Wu Q; Song J; Wang L; Li G
Eur J Pharmacol; 2016 Jul; 782():14-20. PubMed ID: 27112664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
